Low CD86 expression is a predictive biomarker for clinical response to the therapeutic human papillomavirus vaccine IGMKK16E7: results of a post hoc analysis.

JNCI Cancer Spectr · 2024 · PMC11528511 · PMID 39302712

Europe PMC DOI

hedged sentence

0.0940

closest p · 1.9× alpha

0.0940

boldest claim

The sentences

a nonsignificant trendP = .094so close (0.05 < p ≤ 0.1)

CD103 levels also showed a nonsignificant trend toward lower gene expression in the complete response group compared with the incomplete response group ( P = .094).

also in 5,406 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.